ENDRA Life Sciences Inc. — Director's Dealing 2020

May 22, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2020-05-21

Reporting Person: Basenese Lou (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-21	Common Stock	P	10000	$0.71	Acquired	59068	Direct

Footnotes

F1: Includes unvested restricted stock units.